Magda Sobieszczyk
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS Research and Interventions 2
- HIV/AIDS drug development and treatment 2
- Tuberculosis Research and Epidemiology 1
- Virology 4
- HIV Research and Treatment 4
- Co-authors
- Barbara Metch (1 shared paper)John H. Eldridge (1 shared paper)Michael D. Lubeck (1 shared paper)Spyros A. Kalams (1 shared paper)David B. Weiner (1 shared paper)Scott Parker (1 shared paper)John Hural (1 shared paper)M. Cardinali (1 shared paper)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)AIDS Research and Human Retroviruses (2 papers)PLoS ONE (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)The International Journal of Tuberculosis and Lung Disease (1 paper)
- Partner nations
- United StatesPeruThailand
In The Last Decade
Magda Sobieszczyk
7 papers receiving 239 citations
Peers
Comparison fields: 5 of 41
- Molecular Medicine 90
- Virology 43
- Applied Microbiology and Biotechnology 16
- Critical Care and Intensive Care Medicine 16
- Pharmacology 53
Countries citing papers authored by Magda Sobieszczyk
This map shows the geographic impact of Magda Sobieszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Sobieszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Sobieszczyk more than expected).
Fields of papers citing papers by Magda Sobieszczyk
This network shows the impact of papers produced by Magda Sobieszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Sobieszczyk. The network helps show where Magda Sobieszczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside Magda Sobieszczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 119 | |
| 2 | 2012 | 91 | |
| 3 | 2010 | 15 | |
| 4 | 2010 | 11 | |
| 5 | 2017 | 4 | |
| 6 | 2014 | 1 | |
| 7 | 2014 | 1 |
About Magda Sobieszczyk
Magda Sobieszczyk is a scholar working on Infectious Diseases, Virology, Oncology, Epidemiology and Molecular Medicine, having authored 7 papers that have together received 242 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (2 papers), HIV/AIDS drug development and treatment (2 papers), Viral-associated cancers and disorders (1 paper), Tuberculosis Research and Epidemiology (1 paper), Antibiotic Resistance in Bacteria (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Molecular Medicine (90 citations), Virology (43 citations), Applied Microbiology and Biotechnology (16 citations), Critical Care and Intensive Care Medicine (16 citations) and Pharmacology (53 citations). Magda Sobieszczyk has collaborated with scholars based in United States, Peru and Thailand. Frequent co-authors include Barbara Metch, John H. Eldridge, Michael D. Lubeck, Spyros A. Kalams, David B. Weiner, Scott Parker, John Hural, M. Cardinali, Xia Jin and Marnie Elizaga. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS Research and Human Retroviruses, PLoS ONE, Journal of Antimicrobial Chemotherapy and The International Journal of Tuberculosis and Lung Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.